Listed

Tempest Therapeutics, Inc.: Form 10-K for the period ended Dec 31, 2014

Filed with the SEC on Mar 16, 2015 and accepted by EDGAR at Mar 16, 2015, 16:41 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2014-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Research and development12 months2014-01-01 to 2014-12-31$21.8mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative12 months2014-01-01 to 2014-12-31$26.1mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income12 months2014-01-01 to 2014-12-31−$47.9mus-gaap:OperatingIncomeLoss
Income tax12 months2014-01-01 to 2014-12-31$0us-gaap:IncomeTaxExpenseBenefit
Net income12 months2014-01-01 to 2014-12-31−$49.5mus-gaap:NetIncomeLoss
Diluted EPS12 months2014-01-01 to 2014-12-31−$2.19us-gaap:EarningsPerShareBasicAndDiluted
Capital expenditure12 months2014-01-01 to 2014-12-31$2.8mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2014-12-31$6.4mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2014-12-31$61.9mus-gaap:AssetsCurrent
Total assetsAt period end2014-12-31$65.6mus-gaap:Assets
Current liabilitiesAt period end2014-12-31$10.2mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2014-12-31$10.2mus-gaap:Liabilities
Shareholders' equityAt period end2014-12-31$55.3mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001047469-15-002286. Last ingested by Listed: Nov 15, 2026, 00:20 ET. Listed shows no prices and gives no investment advice.